Jamieson Wellness Inc. (TSE:JWEL – Get Free Report) traded down 0.1% during mid-day trading on Thursday . The company traded as low as C$41.74 and last traded at C$41.89. 55,886 shares were traded during mid-day trading, a decline of 37% from the average session volume of 88,848 shares. The stock had previously closed at C$41.93.
Wall Street Analysts Forecast Growth
Separately, Canadian Imperial Bank of Commerce set a C$43.00 target price on Jamieson Wellness and gave the company an “outperform” rating in a report on Tuesday, March 24th. Four analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of C$44.50.
View Our Latest Stock Analysis on Jamieson Wellness
Jamieson Wellness Price Performance
Jamieson Wellness (TSE:JWEL – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported C$0.17 EPS for the quarter. The business had revenue of C$169.75 million during the quarter. Jamieson Wellness had a net margin of 8.71% and a return on equity of 15.25%. Analysts predict that Jamieson Wellness Inc. will post 2.1438892 EPS for the current fiscal year.
Jamieson Wellness Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 15th were paid a $0.23 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.92 annualized dividend and a dividend yield of 2.2%. Jamieson Wellness’s dividend payout ratio (DPR) is presently 52.02%.
About Jamieson Wellness
Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.
Featured Stories
- Five stocks we like better than Jamieson Wellness
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
